Kintsugi, a platform that uses vocal biomarkers to help identify conditions like anxiety and depression, wrapped up its seed-funding round, raising a total of $8 million.
The round was led by Acrew Capital, with participation from Darling Ventures, Techstars, On Deck and Adam Grosser, who also serves as an advisor for Kintsugi. The company received funding from the National Science Foundation and...
